Rapid, reliable evidence generation for pregnancy studies

Advance pregnancy health with Aetion Rapid Start: Pregnancy

Request a Demo

Addressing a longstanding gap in the healthcare system

  • Clinical trials often exclude pregnant patients
  • Pregnancy registries alone are not sufficient, are costly, and take years to complete
  • Real-world datasets linking pregnant patients to infants may exclude critical data elements and are complex to analyze
Image for aetion-study

Generate rapid, reliable evidence for pregnancy studies

Aetion Rapid Start: Pregnancy combines the scientific rigor of Aetion Evidence Platform® (AEP) and our standard-setting regulatory consultancy with pregnancy-specific turnkey components to simplify the preparation and analysis of data of pregnant patients linked to their infants.

Watch this webinar for more details on this offering, including a platform demo.

Image for Reliable-Evidence-Slide HIRES

Fit-for-purpose data identified

Our data-passionate scientists assessed many datasets of pregnant patients linked to their infants for fitness against FDA guidelines. We advised on a HIPAA-compliant dataset that includes critical elements like race, ethnicity, and mortality.

Image for Group 49

Data optimized for longitudinal analysis

Data of pregnant patients linked to their infants is already ingested onto AEP and optimized for longitudinal analysis—no need to prepare complex, time-based, and cross-walked data for analysis.

Image for Group 42

Mother and infant outcomes preserved

Data on both pregnant patients and their infant(s) are represented on the same longitudinal timeline in AEP to streamline analysis of the set, while preserving individual data elements.

Image for Group 39

Pregnancy-specific measures

Our measure library of pregnancy-specific, difficult-to-code clinical definitions (e.g., gestational age, last menstrual period, preterm delivery, infant outcomes) simplifies, accelerates, and scales complex analysis.

Image for Group 41

“The issue of representation in medical and drug development research is both clinically significant and a major contributor to disparities in health equity. Without reliable evidence on how health interventions affect pregnant people and their infants, how can we ensure they’re receiving the same caliber of safe, effective, and high-quality treatment as their non-pregnant peers? True health equity requires better-informed pregnancy care – and it should start at birth.”

— Wendy Turenne
SVP Real-World Data and Delivery Operations, Aetion